[Recurrent facial herpes simplex. Treatment with active paramunization].
132 patients with herpes simplex manifestations were treated with PIND, a heterologous pox-virus-antigen, that stimulates T-cells and macrophages. The shortening of duration of the disease, the subsequent relief from pain and the decrease in frequency of recurrence was proven.